0 likes | 7 Views
Organ-on-chip (OOC) technology, also known as "organ chip" or "organoid chip" technology, is an innovative approach that aims to recreate the physiological and functional characteristics of human organs on a microscale platform. It involves the use of microfluidic systems and 3D cell culture techniques to mimic the microenvironment and cellular interactions found in living organs. OOC technology has gained significant attention in recent years due to its potential to revolutionize drug discovery, toxicology testing, and personalized medicine.
E N D
Organ On ChipMarket Research Report to Witness Huge Growth by 2023-2029 Powered by HTF Market Intelligence Consulting Pvt. Ltd.
Market Definition & Scope Organ-on-a-chip (OOC) refers to a microfluidic cell culture device that simulates the activities, mechanics, and physiological responses of entire organs or organ systems. These devices aim to replicate the complex microenvironment of human organs in order to study biological processes, drug responses, and disease mechanisms in a more realistic and controlled manner compared to traditional cell cultures. Reports powered by HTF Market Intelligence Consulting Pvt. Ltd.
Market Type • Liver-on-Chip • Lung-on-Chip • Heart-on-Chip • Kidney-on-Chip • Others Powered by HTF Market Intelligence Consulting Pvt. Ltd.
Market Application • Drug Discovery and Development • Disease Modeling • Toxicology Testing • Others Powered by HTF Market Intelligence Consulting Pvt. Ltd.
Key Players • Some of the key players profiled in the study are - • Emulate, Inc. (United States) • TissUse GmbH (Germany) • MIMETAS B.V. (Netherlands) • Hesperos, Inc. (United States) • CN Bio Innovations Ltd. (United Kingdom) • InSphero AG (Switzerland) • Kirkstall Ltd. (United Kingdom) • SynVivo, Inc. (United States) • AxoSim Technologies LLC (United States) • Nortis, Inc. (United States) Powered by HTF Market Intelligence Consulting Pvt. Ltd.
Regions • If opting for the Global Organ On Chip marketthen the below country analysis would be included: • North America (the USA, Canada, and Mexico) • Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe) • Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC) • South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.) • The Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA) Powered by HTF Market Intelligence Consulting Pvt. Ltd.
Sample Report Organ-on-chip (OOC) technology, also known as "organ chip" or "organoid chip" technology, is an innovative approach that aims to recreate the physiological and functional characteristics of human organs on a microscale platform. It involves the use of microfluidic systems and 3D cell culture techniques to mimic the microenvironment and cellular interactions found in living organs. OOC technology has gained significant attention in recent years due to its potential to revolutionize drug discovery, toxicology testing, and personalized medicine. Traditional in vitro models and animal testing often fail to accurately mimic human physiology and predict human responses to drugs and diseases. Get free access to sample report @ https://www.htfmarketintelligence.com/sample-report/global-organ-on-chip-market Powered by HTF Market Intelligence Consulting Pvt. Ltd.
Contact Us Contact Us :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedPhone: +1 434 322 0091sales@htfmarketintelligence.comConnect with us atLinkedIn | Facebook | Twitter Powered by HTF Market Intelligence Consulting Pvt. Ltd.